Similarly, data pooling was not possible for CSF opening pressure or changes in ICP, as only one study [7] reported a significant ICP reduction in IIH patients treated with the GLP‐1 RA exenatide versus placebo‐treated controls. Here, GLP1R is linked to pseudotumor cerebri.